David Damoiseaux - Search Results

Year	Number of Results
2020	1
2021	2
2022	3
2023	4
2024	1

1

Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk.

Damoiseaux D, Amant F, Beijnen JH, Barnett S, Veal GJ, Huitema ADR, Dorlo TPC. Damoiseaux D, et al. CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):1931-1944. doi: 10.1002/psp4.13043. Epub 2023 Oct 5. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37798909 Free PMC article.

2

Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach.

Damoiseaux D, Centanni D, Beijnen JH, Amant F, Huitema ADR, Dorlo TPC. Damoiseaux D, et al. Clin Pharmacokinet. 2023 Jul;62(7):969-980. doi: 10.1007/s40262-023-01251-5. Epub 2023 May 8. Clin Pharmacokinet. 2023. PMID: 37154994 Free PMC article.

3

Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis.

Damoiseaux D, Schinkel AH, Beijnen JH, Huitema ADR, Dorlo TPC. Damoiseaux D, et al. Clin Transl Sci. 2024 Jan;17(1):e13668. doi: 10.1111/cts.13668. Epub 2023 Dec 1. Clin Transl Sci. 2024. PMID: 38037826 Free PMC article. Review.

4

Population Pharmacokinetic Modelling to Support the Evaluation of Preclinical Pharmacokinetic Experiments with Lorlatinib.

Damoiseaux D, Li W, Beijnen JH, Schinkel AH, Huitema ADR, Dorlo TPC. Damoiseaux D, et al. J Pharm Sci. 2022 Feb;111(2):495-504. doi: 10.1016/j.xphs.2021.09.029. Epub 2021 Sep 23. J Pharm Sci. 2022. PMID: 34563535 Free article.

5

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs.

Damoiseaux D, Li W, Martínez-Chávez A, Beijnen JH, Schinkel AH, Huitema ADR, Dorlo TPC. Damoiseaux D, et al. Pharmaceuticals (Basel). 2022 Jul 13;15(7):860. doi: 10.3390/ph15070860. Pharmaceuticals (Basel). 2022. PMID: 35890158 Free PMC article.

6

Presence of Five Chemotherapeutic Drugs in Breast Milk as a Guide for the Safe Use of Chemotherapy During Breastfeeding: Results From a Case Series.

Damoiseaux D, Calpe S, Rosing H, Beijnen JH, Huitema ADR, Lok C, Dorlo TPC, Amant F. Damoiseaux D, et al. Clin Pharmacol Ther. 2022 Aug;112(2):404-410. doi: 10.1002/cpt.2626. Epub 2022 May 18. Clin Pharmacol Ther. 2022. PMID: 35486426

7

High accumulation of nivolumab in human breast milk: A case report.

de Jong K, Damoiseaux D, Pluim D, Rosing H, Beijnen JH, van Thienen H, Dorlo TPC, Huitema ADR, Amant F. de Jong K, et al. Among authors: damoiseaux d. Biomed Pharmacother. 2023 Oct;166:115354. doi: 10.1016/j.biopha.2023.115354. Epub 2023 Aug 23. Biomed Pharmacother. 2023. PMID: 37625324 Free article.

8

A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.

de Weger VA, Vermunt MAC, Stuurman FE, Burylo AM, Damoiseaux D, Hendrikx JJMA, Sawicki E, Moes JJ, Huitema ADR, Nuijen B, Rosing H, Mergui-Roelvink M, Beijnen JH, Marchetti S. de Weger VA, et al. Among authors: damoiseaux d. Clin Pharmacol Drug Dev. 2021 Jun;10(6):607-621. doi: 10.1002/cpdd.880. Epub 2020 Oct 5. Clin Pharmacol Drug Dev. 2021. PMID: 33021083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year